In-vitro Transcription Templates Market Size & Share Report, 2032

In-vitro Transcription Templates Market - By Product Type (DNA Templates, RNA Templates, Templates & Transcription Kits), Disease (Cancer, Infectious, Genetic Disease), Treatment (Vaccine, Therapeutic), Research Stage, End-use – Global Forecast (2024 – 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Advancements in genomics and transcriptomics

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing demand for mRNA vaccines and therapeutics

3.2.1.3&nbsp;&nbsp;&nbsp;Research and development in molecular biology

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Limited accessibility and affordability

3.2.2.2&nbsp;&nbsp;&nbsp;Stringent regulatory challenges

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technological landscape

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.4&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; DNA templates

5.3&nbsp;&nbsp;&nbsp; RNA templates

5.4&nbsp;&nbsp;&nbsp; Templates and transcription kits

5.5&nbsp;&nbsp;&nbsp; Other product types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Disease, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Cancer

6.2.1&nbsp;&nbsp;&nbsp; Lung cancer

6.2.2&nbsp;&nbsp;&nbsp; Breast cancer

6.2.3&nbsp;&nbsp;&nbsp; Colorectal cancer

6.2.4&nbsp;&nbsp;&nbsp; Prostate cancer

6.2.5&nbsp;&nbsp;&nbsp; Leukemia

6.2.6&nbsp;&nbsp;&nbsp; Ovarian cancer

6.2.7&nbsp;&nbsp;&nbsp; Other cancers

6.3&nbsp;&nbsp;&nbsp; Infectious disease

6.3.1&nbsp;&nbsp;&nbsp; Influenza

6.3.2&nbsp;&nbsp;&nbsp; Ebola virus

6.3.3&nbsp;&nbsp;&nbsp; Hepatitis C virus

6.3.4&nbsp;&nbsp;&nbsp; Human immunodeficiency virus (HIV)

6.3.5&nbsp;&nbsp;&nbsp; Dengue virus

6.3.6&nbsp;&nbsp;&nbsp; Other infectious diseases

6.4&nbsp;&nbsp;&nbsp; Lifestyle disease

6.5&nbsp;&nbsp;&nbsp; Genetic disease

6.6&nbsp;&nbsp;&nbsp; Other diseases

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Treatment, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Vaccine

7.3&nbsp;&nbsp;&nbsp; Therapeutic

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Research Stage, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Exploratory

8.3&nbsp;&nbsp;&nbsp; Clinical

Chapter 9&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-use, 2021 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Biotechnology and pharmaceutical companies

9.3&nbsp;&nbsp;&nbsp; Academic and research institutes

9.4&nbsp;&nbsp;&nbsp; Contract research organizations

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Netherlands

10.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; Japan

10.4.2&nbsp;&nbsp;&nbsp; China

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; South Korea

10.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.2&nbsp;&nbsp;&nbsp; South Africa

10.6.3&nbsp;&nbsp;&nbsp; UAE

10.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Agilent Technologies Inc.

11.2&nbsp;&nbsp;&nbsp; Bio-Synthesis Inc.

11.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories Inc.

11.4&nbsp;&nbsp;&nbsp; CINVEN LIMITED

11.5&nbsp;&nbsp;&nbsp; Danaher Corporation

11.6&nbsp;&nbsp;&nbsp; Enzynomics Co Ltd.

11.7&nbsp;&nbsp;&nbsp; Enzo Biochem Inc.

11.8&nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd.

11.9&nbsp;&nbsp;&nbsp; Illumina Inc.

11.10&nbsp;&nbsp;&nbsp; LGC Limited

11.11&nbsp;&nbsp;&nbsp; Merck KGaA

11.12&nbsp;&nbsp;&nbsp; Promega Corporation

11.13&nbsp;&nbsp;&nbsp; Qiagen N.V.

11.14&nbsp;&nbsp;&nbsp; Takara Bio Inc.

11.15&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc. 
&nbsp; &nbsp;

Invitro Transcription Templates Market

Get a free sample of this report